{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:01:35Z","timestamp":1784559695368,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Science and Health Joint Medical Research Project of China","award":["2024MSXM151"],"award-info":[{"award-number":["2024MSXM151"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02193-3","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:24:57Z","timestamp":1779693897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lack of real-world evidence on active surveillance in Chinese patients with prostate cancer: insights from a 10-year cohort and a physician survey"],"prefix":"10.1186","volume":"26","author":[{"given":"Peng","family":"Xian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangjun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haike","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"2","key":"2193_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, et al. 2022 Update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023;84(2):191\u2013206.","journal-title":"Eur Urol"},{"issue":"3","key":"2193_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2193_CR3","doi-asserted-by":"publisher","first-page":"26338","DOI":"10.1038\/s41598-024-77863-z","volume":"14","author":"J Chen","year":"2024","unstructured":"Chen J, He L, Ni Y, et al. Prevalence and associated risk factors of prostate cancer among a large Chinese population. Sci Rep. 2024;14(1):26338.","journal-title":"Sci Rep"},{"issue":"5","key":"2193_CR4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s43018-025-00907-4","volume":"5","author":"Z Wang","year":"2025","unstructured":"Wang Z, Xu W, Wan F, et al. Prostate cancer in China: epidemiological trends, genomic insights, and future directions for optimized management. J Natl Cancer Cent. 2025;5(5):474\u201385.","journal-title":"J Natl Cancer Cent"},{"key":"2193_CR5","doi-asserted-by":"crossref","unstructured":"Wang S, Ji Y, Ren M, et al. Estimating the proportion of overdiagnosis among prostate, breast, and thyroid cancers in China: findings from the global burden of disease 2019. Curr Oncol. 2024;31(9):5643-5651.","DOI":"10.3390\/curroncol31090418"},{"key":"2193_CR6","doi-asserted-by":"crossref","unstructured":"Cornford P, Van Den Bergh R C N, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 Update. Part I: Screening, diagnosis, and local treatment with curative intent. Eur Urol., 2024;86(2):148-163.","DOI":"10.1016\/j.eururo.2024.03.027"},{"key":"2193_CR7","unstructured":"Schaeffer E M, Srinivas S, Adra N, et al. NCCN Guidelines\u00ae insights: prostate cancer, version 3.2024.\u00a0J Natl Compr Canc Netw. 2024;22(3):140-150."},{"issue":"6","key":"2193_CR8","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.21037\/tau-20-1370","volume":"10","author":"DK Shill","year":"2021","unstructured":"Shill DK, Roobol MJ, Ehdaie B, et al. Active surveillance for prostate cancer. Transl Androl Urol. 2021;10(6):2809\u201319.","journal-title":"Transl Androl Urol"},{"issue":"17","key":"2193_CR9","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","volume":"388","author":"FC Hamdy","year":"2023","unstructured":"Hamdy FC, Donovan JL, Lane JA, et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2023;388(17):1547\u201358.","journal-title":"N Engl J Med"},{"issue":"10","key":"2193_CR10","doi-asserted-by":"publisher","first-page":"e2338039","DOI":"10.1001\/jamanetworkopen.2023.38039","volume":"6","author":"G Ciccone","year":"2023","unstructured":"Ciccone G, De Luca S, Oderda M, et al. Patient and context factors in the adoption of active surveillance for low-risk prostate cancer. JAMA Netw Open. 2023;6(10):e2338039.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2193_CR11","doi-asserted-by":"publisher","first-page":"e70433","DOI":"10.1111\/iju.70433","volume":"33","author":"A Sugino","year":"2026","unstructured":"Sugino A, Miyazawa Y, Nakazawa S, et al. Active surveillance for localized prostate cancer: a retrospective single-center study. Int J Urol. 2026;33(3):e70433.","journal-title":"Int J Urol"},{"issue":"10","key":"2193_CR12","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.7150\/jca.25113","volume":"9","author":"F Zhao","year":"2018","unstructured":"Zhao F, Shen J, Yuan Z, et al. Trends in treatment for prostate cancer in china: preliminary patterns of care study in a single institution. J Cancer. 2018;9(10):1797\u2013803.","journal-title":"J Cancer"},{"issue":"6","key":"2193_CR13","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.7150\/jca.29595","volume":"10","author":"Y Wei","year":"2019","unstructured":"Wei Y, Liu L, Li X, et al. Current treatment for low-risk prostate cancer in China: a national network Survey. J Cancer. 2019;10(6):1496\u2013502.","journal-title":"J Cancer"},{"issue":"10","key":"2193_CR14","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S1470-2045(14)70361-4","volume":"15","author":"JA Lane","year":"2014","unstructured":"Lane JA, Donovan JL, Davis M, et al. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol. 2014;15(10):1109\u201318.","journal-title":"Lancet Oncol"},{"key":"2193_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.euros.2023.04.006","volume":"52","author":"MS Ahlberg","year":"2023","unstructured":"Ahlberg MS, Garmo H, Holmberg L, et al. Variations in the uptake of active surveillance for prostate cancer and its impact on outcomes. Eur Urol Open Sci. 2023;52:166\u201373.","journal-title":"Eur Urol Open Sci"},{"key":"2193_CR16","doi-asserted-by":"crossref","unstructured":"De Vos I I, Luiting H B, Roobol M J. Active surveillance for prostate cancer: past, current, and future trends. J Pers Med. 2023;13(4):629.","DOI":"10.3390\/jpm13040629"},{"issue":"2","key":"2193_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.euo.2024.07.003","volume":"8","author":"C Bangma","year":"2024","unstructured":"Bangma C, Doan P, Zhu L, et al. Has active surveillance for prostate cancer become safer? Lessons learned from a global clinical registry. European Urology Oncology. 2024;8(2):324\u201337.","journal-title":"European Urology Oncology"},{"issue":"9","key":"2193_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/jjco\/hyae079","volume":"54","author":"T Kawai","year":"2024","unstructured":"Kawai T, Onozawa M, Taguchi S, et al. Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan: a nationwide multi-institutional study. Jpn J Clin Oncol. 2024;54(9):1045\u201351.","journal-title":"Jpn J Clin Oncol"},{"key":"2193_CR19","doi-asserted-by":"crossref","unstructured":"Al Hussein Al Awamlh B, Barocas DA, Zhu A, et al. Use of active surveillance vs definitive treatment among men with low- and favorable intermediate-risk prostate cancer in the US Between 2010 and 2018. JAMA Intern Med. 2023;183(6):608-611.","DOI":"10.1001\/jamainternmed.2022.7100"},{"key":"2193_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2340\/sju.v59.40123","volume":"59","author":"J Maljkovic","year":"2024","unstructured":"Maljkovic J, Bill-Axelson A, H\u00e5llberg H, et al. Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study. Scand J Urol. 2024;59:200\u20136.","journal-title":"Scand J Urol"},{"issue":"3","key":"2193_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","volume":"33","author":"L Klotz","year":"2014","unstructured":"Klotz L, Vesprini D, Sethukavalan P, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol. 2014;33(3):272\u20137.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2193_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/iju.15102","volume":"30","author":"T Kato","year":"2022","unstructured":"Kato T, Tohi Y, Honda T, et al. A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer. Int J Urol. 2022;30(3):289\u201397.","journal-title":"Int J Urol"},{"issue":"1","key":"2193_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4111\/icu.20200206","volume":"62","author":"SH Song","year":"2020","unstructured":"Song SH, Kim JK, Lee H, et al. A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up. Investigative and Clinical Urology. 2020;62(1):32\u20138.","journal-title":"Investigative and Clinical Urology"},{"issue":"6","key":"2193_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/jjco\/hyz053","volume":"49","author":"J Youl Lee","year":"2019","unstructured":"Youl Lee J, Taniguchi T, Zhang K, et al. Report of the forth Asian prostate cancer (A-CaP) study meeting. Jpn J Clin Oncol. 2019;49(6):581\u20136.","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"2193_CR25","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.21037\/qims-24-1834","volume":"15","author":"F He","year":"2025","unstructured":"He F, Cheng X, Yuan J, et al. Current practice and perceptions of multiparametric magnetic resonance imaging and multiparametric ultrasound and prostatic biopsies for prostate cancer diagnosis in China: a nationwide survey. Quant Imaging Med Surg. 2025;15(5):4629\u201340.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"2193_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4143\/crt.2016.477","volume":"50","author":"CW Jeong","year":"2017","unstructured":"Jeong CW, Hong SK, Byun SS, et al. Selection criteria for active surveillance of patients with prostate cancer in korea: a multicenter analysis of pathology after radical prostatectomy. Cancer Res Treat. 2017;50(1):265\u201374.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"2193_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12885-021-08386-3","volume":"21","author":"SD Ellis","year":"2021","unstructured":"Ellis SD, Hwang S, Morrow E, et al. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists. BMC Cancer. 2021;21(1):649.","journal-title":"BMC Cancer"},{"issue":"2","key":"2193_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s13629-017-0168-1","volume":"7","author":"P Stattin","year":"2017","unstructured":"Stattin P, Sandin F, Hellstr\u00f6m K, et al. The national prostate cancer register of Sweden. Tijdschr Urol. 2017;7(2):50\u20139.","journal-title":"Tijdschr Urol"},{"issue":"9","key":"2193_CR29","doi-asserted-by":"publisher","first-page":"e008953","DOI":"10.1136\/bmjopen-2015-008953","volume":"5","author":"J Wade","year":"2015","unstructured":"Wade J, Holding PN, Bonnington S, et al. Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial. BMJ Open. 2015;5(9):e008953.","journal-title":"BMJ Open"},{"issue":"1","key":"2193_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12894-022-01036-1","volume":"22","author":"ML Wroclawski","year":"2022","unstructured":"Wroclawski ML, Amaral BS, Kayano PP, et al. Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil. BMC Urol. 2022;22(1):86.","journal-title":"BMC Urol"},{"issue":"2","key":"2193_CR31","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1245\/s10434-018-6863-1","volume":"26","author":"SP Kim","year":"2018","unstructured":"Kim SP, Gross CP, Shah ND, et al. Perceptions of barriers towards active surveillance for low-risk prostate cancer: results from a national survey of radiation oncologists and urologists. Ann Surg Oncol. 2018;26(2):660\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"2193_CR32","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4111\/kju.2010.51.10.665","volume":"51","author":"N Lawrentschuk","year":"2010","unstructured":"Lawrentschuk N, Klotz L. Active surveillance for favorable-risk prostate cancer: a short review. Korean J Urol. 2010;51(10):665\u201370.","journal-title":"Korean J Urol"},{"issue":"6","key":"2193_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.4103\/aja202423","volume":"26","author":"L Cerbone","year":"2024","unstructured":"Cerbone L, Regine G, Calabr\u00f2 F. Active surveillance in low- and intermediate-risk prostate cancer. Asian J Androl. 2024;26(6):582\u20133.","journal-title":"Asian J Androl"},{"key":"2193_CR34","doi-asserted-by":"publisher","first-page":"175883592312165","DOI":"10.1177\/17588359231216582","volume":"16","author":"E Chiong","year":"2024","unstructured":"Chiong E, Saad M, Hamid ARaH, et al. Prostate cancer management in Southeast Asian countries: a survey of clinical practice patterns. Ther Adv Med Oncol. 2024;16:17588359231216582.","journal-title":"Ther Adv Med Oncol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02193-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02193-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02193-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:03:10Z","timestamp":1784556190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02193-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2193"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02193-3","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the Ethics Review Committee of Chongqing University Cancer Hospital. All participants signed written informed consent forms after fully understanding the study's purpose, procedures, potential risks, benefits, and confidentiality measures. All procedures complied with the principles of the Declaration of Helsinki. Participation was entirely voluntary, and participants had the right to withdraw at any time without affecting their medical care. All personal data was anonymized to ensure privacy. For questionnaires, all participants also provided informed consent and anonymized their data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"173"}}